Additional Stock Awards Clause Samples

Additional Stock Awards. In addition, the Company may grant the Executive additional stock awards at such times and on such terms as may be decided from time to time by the Board or its Compensation Committee, in their sole discretion.
Additional Stock Awards. Subject to approval by the Company’s Compensation Committee, in consultation with the independent members of the Board of Directors, Executive will be eligible to receive additional Stock Awards on terms to be determined by the Compensation Committee at the time of any such grant. The determination whether to grant any additional Stock Award to Executive is in the sole discretion of the Compensation Committee, in consultation with the independent members of the Board of Directors. For all purposes of this Agreement, “Stock Awards” shall mean any rights granted by the Company to Executive with respect to the common stock of the Company, including, without limitation, stock options, stock appreciation rights, restricted stock, stock bonuses and restricted stock units.
Additional Stock Awards. Subject to approval by the Compensation Committee, Executive will be eligible to receive additional equity incentive awards with respect to the Company’s common stock on terms to be determined by the Compensation Committee at the time of any such grant. The determination whether to grant any additional equity incentive awards to Executive, and the form and terms of any such equity incentive award, is in the sole discretion of the Compensation Committee.
Additional Stock Awards. In addition, NuGene may g▇▇▇▇ ▇▇▇▇▇▇▇▇ additional stock awards at such times and on such terms as may be decided from time to time by the Board or its Compensation Committee, in its sole discretion.
Additional Stock Awards. Subject to the foregoing additional Stock shall be awarded as follows: (1) Time Vesting stock awards 2,000 Series B Preferred shares convertible into 2,000,000 common shares for each calendar year of service in the Executive Position for the next four (4) years (8,000 Series B Preferred shares in aggregate), which shall vest and become exercisable as follows: (a) as to 1,000 shares on September 30, 2024; (b) as to 1,000 shares on December 31, 2024; (c) as to 1,000 shares on June 30, 2025; (d) as to 1,000 shares on December 31, 2025; (e) as to 1,000 shares on June 30, 2026; (f) as to 1,000 shares on December 31, 2026; (g) as to 1,000 shares on June 30, 2027; and (h) as to 1,000 shares on December 31, 2027.